EP300 - E1A binding protein p300 Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101088344
EP300 Products (3)
| mRNA | Protein | Name |
|---|---|---|
| XM_003989288.6 | XP_003989337.3 | histone acetyltransferase p300 isoform X2 |
| XM_045062431.1 | XP_044918366.1 | histone acetyltransferase p300 isoform X1 |
| XM_045062432.1 | XP_044918367.1 | histone acetyltransferase p300 isoform X3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
histone acetyltransferase p300 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Pre-clinical Phase
Bioactive Molecules
(150)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-107455 | A-485 | Inhibitor | 99.87% | Unkown |
| HY-13823 | C646 | 99.88% | Unkown | |
| HY-14428 | ICG-001 | 99.86% | Unkown | |
| HY-15826 | SGC-CBP30 | Inhibitor | 99.83% | Unkown |
| HY-15887 | MG 149 | 99.60% | Unkown | |
| HY-N2020 | Anacardic Acid | Inhibitor | 98.49% | Unkown |
| HY-110127 | NU9056 | 98.81% | Unkown | |
| HY-134582 | dCBP-1 | 99.37% | Unkown | |
| HY-107569 | Garcinol | 98.85% | Unkown | |
| HY-W105310A | Croconic acid disodium | 99.98% | Unkown | |
| HY-138536 | PROTAC CBP/P300 Degrader-1 | 99.97% | Unkown | |
| HY-124696 | PU139 | Inhibitor | 99.51% | Unkown |
| HY-W013274 | CPTH2 | 99.82% | Unkown | |
| HY-116673 | TTK21 | Activator | 99.39% | Unkown |
| HY-136285 | CPI-1612 | Inhibitor | 99.75% | Unkown |
| HY-158113 | CBPD-409 | Degrader | 99.38% | Unkown |
| HY-N0005R | Curcumin (Standard) | 98.01% | Unkown | |
| HY-138539 | CBP/p300 ligand 2 | Ligand | 99.39% | Unkown |
| HY-145765 | JQAD1 | 98.24% | Unkown | |
| HY-124960 | CTPB | Activator | ≥99.0% | Unkown |
| HY-100482 | CPI-637 | Inhibitor | 99.94% | Unkown |
| HY-100726 | GNE-272 | Inhibitor | 99.60% | Unkown |
| HY-19541 | I-CBP112 | 98.43% | Unkown | |
| HY-154984 | JET-209 | Degrader | / | Unkown |
| HY-N2345 | Procyanidin B3 | Inhibitor | 99.92% | Unkown |
| HY-10593 | IQ 1 | Modulator | 99.13% | Unkown |
| HY-161369 | CBPD-268 | Degrader | 99.23% | Unkown |
| HY-P10238 | MYBMIM | Inducer | 99.96% | Unkown |
| HY-100671 | L002 | Inhibitor | 99.44% | Unkown |
| HY-100734 | Histone Acetyltransferase Inhibitor II | Inhibitor | 98.70% | Unkown |
| HY-173552 | TCIP3 | Inhibitor | 99.30% | Unkown |
| HY-152241 | DS-9300 | Inhibitor | 99.83% | Unkown |
| HY-N0005S | Curcumin-d6 | 99.78% | Unkown | |
| HY-131035 | Lys-CoA TFA | Inhibitor | 98.52% | Unkown |
| HY-101125 | L-Moses | Inhibitor | 99.97% | Unkown |
| HY-128876 | CBP/p300-IN-3 | Inhibitor | 98.01% | Unkown |
| HY-141466A | Crotonyl-CoA tetrasodium | Substrate | 97.85% | Unkown |
| HY-115539 | Windorphen | Inhibitor | 99.75% | Unkown |
| HY-17663 | KMR-206 | 98.86% | Unkown | |
| HY-100697 | TPOP146 | Inhibitor | 98.94% | Unkown |
| HY-111420 | CBP/p300-IN-1 | Inhibitor | 99.71% | Unkown |
| HY-139108 | DCH36_06 | 99.19% | Unkown | |
| HY-RS04405 | EP300 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-147008 | XP-524 | Inhibitor | 98.02% | Unkown |
| HY-134591 | Thalidomide-NH-PEG4-COOH | Inducer | 96.65% | Unkown |
| HY-125847 | Salvianolic acid F | 99.50% | Unkown | |
| HY-147290 | NSC 694623 | Inhibitor | 99.53% | Unkown |
| HY-161483 | CBP/p300 ligand 3 | Inhibitor | 98.82% | Unkown |
| HY-136920 | CBP/p300-IN-8 | Inhibitor | 98.03% | Unkown |
| HY-132197 | CBP/p300-IN-12 | Inhibitor | 99.72% | Unkown |
| HY-120290 | PU141 | Inhibitor | 99.96% | Unkown |
| HY-139148 | UMB298 | Inhibitor | 99.28% | Unkown |
| HY-W877997 | Pomalidomide 5'-pip-acid | 98.06% | Unkown | |
| HY-141546 | Pocenbrodib | Inhibitor | 98.49% | Unkown |
| HY-134592 | Piperidine-GNE-049-N-Boc | 98.48% | Unkown | |
| HY-112359 | C-82 | Inhibitor | 99.91% | Yes |
| HY-146277A | CBP/p300-IN-19 hydrochloride | Inhibitor | 99.00% | Unkown |
| HY-RS04406 | Ep300 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-162259 | QC-182 | Degrader | 98.94% | Unkown |
| HY-128875 | CBP/p300-IN-10 | Inhibitor | 99.74% | Unkown |
| HY-139707 | PROTAC CBP/P300 Degrader-3 | Degrader | 98.55% | Unkown |
| HY-110263 | EML 425 | Inhibitor | 98.04% | Unkown |
| HY-174866 | BT-O2C | Inhibitor | 99.31% | Unkown |
| HY-101125A | L-Moses dihydrochloride | Inhibitor | 99.38% | Unkown |
| HY-184124 | JZY3032 | Inhibitor | / | Unkown |
| HY-100132 | CBP/p300-IN-5 | Inhibitor | ≥97.0% | Unkown |
| HY-101125B | D-Moses | Control | / | Unkown |
| HY-136285A | (R,R)-CPI-1612 | Control | 99.49% | Unkown |
| HY-145386 | (S,S)-CPI-1612 | Control | 99.88% | Unkown |
| HY-147261 | B026 | Inhibitor | / | Unkown |
| HY-151812 | CBP/p300-IN-20 | Inhibitor | 98.03% | Unkown |
| HY-153768 | KAT modulator-1 | Modulator | 98.0% | Unkown |
| HY-168201 | MJP6412 | Degrader | 95.90% | Unkown |
| HY-128761 | CBP/p300-IN-2 | Inhibitor | / | Unkown |
| HY-134621 | P300-IN-1 | Inhibitor | / | Unkown |
| HY-143443 | DS17701585 | Inhibitor | / | Unkown |
| HY-W013274A | CPTH2 hydrochloride | / | Unkown | |
| HY-114510 | PRMT/HKMT-IN-1 | / | Unkown | |
| HY-121009 | CCT077791 | Inhibitor | / | Unkown |
| HY-121089 | P300-IN-5 | Inhibitor | / | Unkown |
| HY-122081 | CPI-644 | Inhibitor | / | Unkown |
| HY-124722 | OHM1 | Inhibitor | / | Unkown |
| HY-128362 | Ep300/CREBBP-IN-8 | Inhibitor | / | Unkown |
| HY-128363 | Ep300/CREBBP-IN-2 | Inhibitor | / | Unkown |
| HY-128364 | Ep300/CREBBP-IN-3 | Inhibitor | / | Unkown |
| HY-128367 | Ep300/CREBBP-IN-4 | Inhibitor | / | Unkown |
| HY-139804 | CTK7A | Inhibitor | / | Unkown |
| HY-139861 | CBP/p300-IN-14 | Inhibitor | / | Unkown |
| HY-143339 | CBP/p300-IN-15 | Inhibitor | / | Unkown |
| HY-143440 | CBP/p300-IN-16 | Inhibitor | / | Unkown |
| HY-143441 | CBP/p300-IN-17 | Inhibitor | / | Unkown |
| HY-143442 | CBP/p300-IN-18 | Inhibitor | / | Unkown |
| HY-146277 | CBP/p300-IN-19 | Inhibitor | / | Unkown |
| HY-146445 | P300 bromodomain-IN-1 | Inhibitor | / | Unkown |
| HY-155229 | CBP/p300-IN-21 | Inhibitor | / | Unkown |
| HY-159587 | P300-IN-4 | Inhibitor | / | Unkown |
| HY-160261S | EP300/CBP-IN-2 | Inhibitor | / | Unkown |
| HY-161250 | Pomalidomide-NH-PEG6-amide-C2-CPI-1612 | / | Unkown | |
| HY-161494 | XYD190 | / | Unkown | |
| HY-161495 | CBP/p300 ligand 4 | / | Unkown | |
| HY-161498 | XYD198 | / | Unkown | |
| HY-161710 | XYD129 | Degrader | / | Unkown |
| HY-161711 | CBP/p300 ligand 5 | / | Unkown | |
| HY-161958 | dCE-2 | / | Unkown | |
| HY-161959 | EP300/CBP ligand 1 | / | Unkown | |
| HY-161960 | EP300/CBP ligand 2 | / | Unkown | |
| HY-162128 | Antitumor agent-130 | Inhibitor | / | Unkown |
| HY-164005 | CBP/EP300 bromodomain receptor-IN-1 | Inhibitor | / | Unkown |
| HY-165413 | KST012174 hydrochloride | Inhibitor | / | Unkown |
| HY-168148S | CZL-046 | Inhibitor | / | Unkown |
| HY-168463 | Y16524 | Inhibitor | / | Unkown |
| HY-168464 | Y16526 | Inhibitor | / | Unkown |
| HY-173641 | MNN-02-155 | / | Unkown | |
| HY-174868 | iP300w | Inhibitor | / | Unkown |
| HY-175898 | CBP/EP300 ligand-1 | / | Unkown | |
| HY-175907 | CBP/p300 ligand 7 | Ligand | / | Unkown |
| HY-176251 | CBP/p300-IN-22 | Inhibitor | / | Unkown |
| HY-179498 | ROCK2-IN-13 | / | Unkown | |
| HY-179657 | PROTAC p300 degrader-2 | Inhibitor | / | Unkown |
| HY-180804 | CZL-077 | Inhibitor | / | Unkown |
| HY-181261 | PROTAC CBP/P300 Degrader-2 | / | Unkown | |
| HY-181669 | P300-IN-6 | Inhibitor | / | Unkown |
| HY-181758 | PROTAC CBP/p300/BRD4 Degrader-1 | / | Unkown | |
| HY-181759 | CBP/p300/BRD4 ligand-1 | Ligand | / | Unkown |
| HY-181852 | CBP/p300 ligand 10 | Degrader | / | Unkown |
| HY-181957 | KB528 | / | Unkown | |
| HY-183251 | PROTAC p300 degrader-1 | Degrader | / | Unkown |
| HY-183802 | PROTAC CBP/P300 Degrader-4 | Degrader | / | Unkown |
| HY-183817 | GNE-781-COOH | Ligand | / | Unkown |
| HY-183818 | CRBN ligand-903 | / | Unkown | |
| HY-183819 | CRBN ligand-903-trans-1,4-cyclohexanediamine-Boc | / | Unkown | |
| HY-183992 | CZL-149 | Inhibitor | / | Unkown |
| HY-184453 | PROTAC CBP/EP300 degrader-1 | / | Unkown | |
| HY-185009 | GSK702 | / | Unkown | |
| HY-185786 | CBP/p300-IN-25 | / | Unkown | |
| HY-186064 | CBP/p300 ligand-Linker Conjugate 3 | / | Unkown | |
| HY-CE00983A | 4-Pentynoyl-Coenzyme A TFA | Substrate | / | Unkown |
| HY-P11829 | ACTR-AD1 2L | Inhibitor | / | Unkown |
| HY-RS04407 | Ep300 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W197205 | SL010110 | / | Unkown | |
| HY-W585171 | CRBN ligand-896 | / | Unkown | |
| HY-123009 | KCN1 | Inhibitor | / | Unkown |
| HY-123758 | XDM-CBP | Inhibitor | / | Unkown |
| HY-141466 | Crotonyl-CoA | Substrate | / | Unkown |
| HY-160260 | EP300/CBP-IN-1 | Inhibitor | / | Unkown |
| HY-161961 | Thalidomide-NH-C10-Boc | / | Unkown | |
| HY-166309 | Crotonyl-CoA tetralithium | Substrate | / | Unkown |
| HY-19541A | I-CBP112 hydrochloride | Inhibitor | / | Unkown |
| HY-N0005S1 | Curcumin-d3 | / | Unkown | |
| HY-W173361 | CBP/p300-IN-24 | Inhibitor | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | EP300 | NCBI | NCBI:2033 |
| Mus musculus | EP300 | NCBI | NCBI:328572 |